Proteomic identification of mitochondrial targets of arginase in human breast cancer

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Singh, Rajan ^a,b   Avliyakulov, Nuraly K ^b   Braga, Melissa ^a   Haykinson, Michael J ^b   Martinez, Luis ^a   Singh, Vikash ^a   Parveen, Meher ^a   Chaudhuri, Gautam ^b   Pervin, Shehla ^a,b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGINASE II; GLYCINE HYDROXYMETHYLTRANSFERASE; MESSENGER RNA; ORNITHINE; PROTEIN BCL 2; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; MITOCHONDRION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; TUMOR XENOGRAFT; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION;

ANIMALS; APOPTOSIS; ARGINASE; ARGININE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GLYCINE HYDROXYMETHYLTRANSFERASE; HUMANS; MASS SPECTROMETRY; MICE; MICE, NUDE; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PROTEOMICS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 84892409748     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079242     Document Type: Article

References (45)

1. Pervin S, Singh R, Chaudhuri G (2008) Nitric oxide, N omega-hydroxy-L-arginine and breast cancer. Nitric Oxide 19: 103-106. doi:10.1016/j.niox.2008.04.016. PubMed: 18474257.
2. Singh R, Pervin S, Karimi A, Cederbaum S, Chaudhuri G (2000) Arginase activity in human breast cancer cell lines: N. (Omega. Retrieved onpublished at whilst December year 1111 from) -hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res 16:3305-3312
3. Chang CI, Liao JC, Kuo L (2001) Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. Cancer Res 61: 1100-1106. PubMed: 11221839.
4. Weigert A, Brüne B (2008) Nitric oxide, apoptosis and macrophage polarization during tumor progression. Nitric Oxide 19: 95-102. doi: 10.1016/j.niox.2008.04.021. PubMed: 18486631.
5. Pervin S, Singh R, Chaudhuri G (2001) Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line. Retrieved onpublished at whilst December year 1111 from MDA-MB-231): potential role of cyclin D1. Proc; Natl Acad Sci USA 98:3583-3588
6. Pervin S, Singh R, Chaudhuri G (2003). Retrieved onpublished at whilst December year 1111 from Nitric-oxide-induced Bax integration into the mitochondrial membrane commits MDA-MB-468 cells to apoptosis: essential role of Akt. Cancer Res 63: 5470-5479.
7. ω -hydroxy-L-arginine- induced apoptosis in MDA-MB-468 cells. Antagonistic effects of Lornithine. J Biol Chem 277:37630-37636.
8. Murdoch C, Giannoudis A, Lewis CE (2004) Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104: 2224-2234. doi:10.1182/blood-2004-03-1109. PubMed: 15231578.
9. Polat MF, Taysi S, Polat S, Böyük A, Bakan E (2003) Elevated serum arginase activity levels in patients with breast cancer. Surg Today 33: 655-661. doi:10.1007/s00595-002-2563-2. PubMed: 12928840.
10. Porembska Z, Luboiński G, Chrzanowska A, Mielczarek M, Magnuska J et al. (2003) Arginase in patients with breast cancer. Clin Chim Acta 328: 105-111. doi:10.1016/S0009-8981(02)00391-1. PubMed: 12559605.
11. Straus B, Cepelak I, Festa G (1992) Arginase, a new marker of mammary carcinoma. Clin Chim Acta 210: 5-12. doi: 10.1016/0009-8981(92)90040-W. PubMed: 1424158.
12. Pervin S, Singh R, Gau CL, Edamatsu, Tamanoi F et al. (2001) Potentiation of nitric oxide-induced apoptosis of MDA-MB-468 cells by farnesyltransferase inhibitor: implications in breast cancer. Cancer Res 61: 4701-4706. PubMed: 11406540.
13. Jung EJ, Avliyakulov NK, Boontheung P, Loo JA, Nel AE (2007) Pro-oxidative DEP chemicals induce heat shock proteins and an unfolding protein response in a bronchial epithelial cell line as determined by DIGE analysis. Proteomics 7: 3906-3918. doi:10.1002/pmic.200700377. PubMed: 17922515.
14. Mayr M, Liem D, Zhang J, Li X, Avliyakulov NK et al. (2009) Proteomic and metabolomic analysis of cardioprotection: Interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts. J Mol Cell Cardiol 46: 268-277. doi:10.1016/j.yjmcc.2008.10.008. PubMed: 19027023.
15. Mosessian S, Avliyakulov NK, Mulholland DJ, Boontheung P, Loo JA et al. (2009) Analysis of PTEN complex assembly and identification of heterogeneous nuclear ribonucleoprotein C as a component of the PTEN-associated complex. J Biol Chem 284: 30159-30166. doi: 10.1074/jbc.M109.027995. PubMed: 19740742.
16. Singh R, Bhasin S, Braga M, Artaza JN, Pervin S et al. (2009) Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways. Endocrinology 150: 1259-1268. PubMed: 18948405.
17. Braga M, Bhasin S, Jasuja R, Pervin S, Singh R (2012) Testosterone inhibits transforming growth factor-β signaling during myogenic differentiation and proliferation of mouse satellite cells: potential role of follistatin in mediating testosterone action. Mol Cell Endocrinol 350: 39-52. doi:10.1016/j.mce.2011.11.019. PubMed: 22138414.
18. Pervin S, Tran L, Urman R, Braga M, Parveen M et al. (2013) Oxidative stress specifically down-regulates survivin to promote breast tumor formation. Br J Cancer 108(4): 848-858. doi:10.1038/bjc.2013.40. PubMed: 23403820.
19. Sancéau J, Poupon MF, Delattre O, Sastre-Garau X, Wietzerbin J (2002) Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide. Oncogene 21: 7700-7709. doi:10.1038/sj.onc.1205881. PubMed: 12400012.
20. Pervin S, Hewison M, Braga M, Tran L, Chun R et al. (2013) Down-regulation of vitamin D receptor in mammospheres: Implications for vitamin D resistance in breast cancer and potential for combination therapy. PLOS ONE 8: e53287. doi:10.1371/journal.pone.0053287. PubMed: 23341935.
21. Buga GM, Singh R, Pervin S, Rogers NE, Schmitz DA et al. (1996) Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production. Am J Physiol 271: H1988-H1998. PubMed: 8945918.
22. Meulemans A (2000) Electrochemical detection of nitroso-arginine as an intermediate between N-hydroxy-arginine and citrulline. An in vitro versus in vivo study using micro carbon electrodes in neuronal nitric oxide synthase and mice brain. Neurosci Lett 294: 125-129. PubMed: 11058803.
23. Tenu JP, Lepoivre M, Moali C, Brollo M, Mansuy D et al. (1999) Effects of the new arginase inhibitor N. (Omega Retrieved onpublished at whilst December year 1111 from) -hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. Nitric Oxide 3:427-438.
24. Singh R, Pervin S, Wu G, Chaudhuri G (2001) Activation of caspase-3 activity and apoptosis in MDA-MB-468 cells by N(omega)-hydroxy-L-arginine, an inhibitor of arginase, is not solely dependent on reduction in intracellular polyamines. Carcinogenesis 22: 1863-1869. doi: 10.1093/carcin/22.11.1863. PubMed: 11698350.
25. Appling DR (1991) Compartmentation of folate-mediated one-carbon metabolism in eukaryotes. FASEB J 5: 2645-2651. PubMed: 1916088.
26. Cybulski RL, Fisher RR (1976) Intramitochondrial localization and proposed metabolic significance of serine transhydroxymethylase. Biochemistry 15: 3183-3187. doi:10.1021/bi00660a004. PubMed: 952851.
27. de Koning TJ, Snell K, Duran M, Berger R, Poll-The BT et al. (2003) Retrieved onpublished at whilst December year 1111 from L-serine in disease and development. Biochem J 371:653-661.
28. Garrow TA, Brenner AA, Whitehead VM, Chen XN, Duncan RG et al. (1993) Cloning of human cDNAs encoding mitochondrial and cytosolic serine hydroxymethyltransferases and chromosomal localization. J Biol Chem 268(16): 11910-11916. PubMed: 8505317.
29. Vijayakrishnan J, Houlston RS (2010) Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica. 95(8): 1405-1414. doi:10.3324/haematol.2010. 022095. PubMed: 20511665.
30. Komlósi V, Hitre E, Pap E, Adleff V, Réti A et al. (2010) SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer. BMC Cancer. 10: 525. doi:10.1186/1471-2407-10-525. PubMed: 20920350.
31. Collin SM, Metcalfe C, Zuccolo L, Lewis SJ, Chen L et al. (2009) Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 18(9): 2528-2539. doi:10.1158/1055-9965.EPI-09-0223. PubMed: 19706844.
32. Snell K, Natsumeda Y, Eble JN, Glover JL, Weber G (1998) Enzymic imbalance in serine metabolism in human colon carcinoma and rat sarcoma. Br J Cancer 57: 87-90. PubMed: 3126791.
33. Farber S, Diamond LK (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist. Retrieved onpublished at whilst December year 1111 from 4-aminopteroyl-glutamic acid. N Engl J Med 238:787-793
34. Muller C (2012) Folate based radiopharmaceuticals for imaging and therapy of cancer and inflammation. Curr Pharm Des 18: 1058-1083. doi:10.2174/ 138161212799315777. PubMed: 22272825.
35. Xia W, Low PS (2010). Retrieved onpublished at whilst December year 1111 from Folate-targeted therapies for cancer. J Med Chem 53:6811-6824.
36. Low PS, Kularatne SA (2009). Retrieved onpublished at whilst December year 1111 from Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol 13:256-262.
37. Leamon CP, Reddy JA, Vetzel M, Dorton R, Westrick E et al. (2008) Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue. Cancer Res 68: 9839-9844. doi:10.1158/0008-5472.CAN-08-2341. PubMed: 19047164.
38. Assaraf YG (2007) Molecular basis of antifolate resistance. Cancer Metastasis Rev 26: 153-181. doi:10.1007/s10555-007-9049-z. PubMed: 17333344.
39. Chang WN, Tsai JN, Chen BH, Huang HS, Fu TF (2007) Serine hydroxymethyltransferase isoforms are differentially inhibited by leucovorin: characterization and comparison of recombinant zebrafish serine hydroxymethyltransferases. Drug Metab Dispos 35: 2127-2137. doi:10.1124/dmd.107. 016840. PubMed: 17664250.
40. Snell K, Riches D (1989) Effects of a triazine antifolate (NSC 127755) on serine hydroxymethyltransferase in myeloma cells in culture. Cancer Lett 44: 217-220. doi:10.1016/0304-3835(89)90064-5. PubMed: 2924288.
41. Singh R, Fouladi-Nashta AA, Li D, Halliday N, Barrett DA et al. (2006) Methotrexate induced differentiation in colon cancer cells is primarily due to purine deprivation. J Cell Biochem 99: 146-155. doi:10.1002/jcb.20908. PubMed: 16598758.
42. Nikiforov MA, Chandriani S, O'Connell B, Petrenko O, Kotenko I et. al.. (2002) A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol Cell Biol 22: 5793-5800. doi:10.1128/MCB. 22.16.5793-5800.2002. PubMed: 12138190.
43. Malt RA, Kingsnorth AN, Lamuraglia GM, Lacaine F, Ross JS (1985) Chemoprevention and chemotherapy by inhibition of ornithine decarboxylase activity and polyamine synthesis: colonic, pancreatic, mammary, and renal carcinomas. Adv Enzyme Regul 24: 93-102. doi: 10.1016/0065-2571(85)90071-8. PubMed: 3939097.
44. Shin H, Cama E, Christianson DW (2004) Design of amino acid aldehydes as transition-state analogue inhibitors of arginase. J Am Chem Soc 126: 10278-10284. doi:10.1021/ja047788w. PubMed: 15315440.
45. Baggio R, Emig FA, Christianson DW, Ash DE, Chakder S et al. (1999) Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor. J Pharmacol Exp Ther 290: 1409-1416. PubMed: 10454520.